Ovarian function after chemotherapy in young breast cancer survivors.

about

Ovarian function after chemotherapy in young breast cancer survivors.

Item

http://www.wikidata.org/entity/Q47124589

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Ovarian function after chemotherapy in young breast cancer survivors.

@en

Ovarian function after chemotherapy in young breast cancer survivors.

@nl

type

Item

label

Ovarian function after chemotherapy in young breast cancer survivors.

@en

Ovarian function after chemotherapy in young breast cancer survivors.

@nl

prefLabel

Ovarian function after chemotherapy in young breast cancer survivors.

@en

Ovarian function after chemotherapy in young breast cancer survivors.

@nl

P1476

Ovarian function after chemotherapy in young breast cancer survivors.

@en

P2093

A Azad

http://www.w3.org/2001/XMLSchema#string

A M F Ali

http://www.w3.org/2001/XMLSchema#string

D C Hodgson

http://www.w3.org/2001/XMLSchema#string

E M Greenblatt

http://www.w3.org/2001/XMLSchema#string

E Warner

http://www.w3.org/2001/XMLSchema#string

G Gingras-Hill

http://www.w3.org/2001/XMLSchema#string

K Hui

http://www.w3.org/2001/XMLSchema#string

K Morarji

http://www.w3.org/2001/XMLSchema#string

O McArdle

http://www.w3.org/2001/XMLSchema#string

S Ahmed

http://www.w3.org/2001/XMLSchema#string

P2860

Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks

Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy

Impact of cancer therapies on ovarian reserve

The transforming growth factor-beta family

A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer

BRCA1 and BRCA2 mutations and female fertility

Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors

Association of cyclophosphamide drug-metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors.

Breast cancer before age 40 years.

Prospective study of fertility concerns and preservation strategies in young women with breast cancer

P304

e494-e502

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3747/CO.24.3335

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29270058

http://www.w3.org/2001/XMLSchema#string

P932

5736488

http://www.w3.org/2001/XMLSchema#string